Vanda Pharmaceuticals Inc.

NasdaqGM:VNDA Stock Report

Market Cap: US$429.7m

Vanda Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:VNDA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Mar 26SellUS$1,276,971Mihael PolymeropoulosIndividual156,235US$8.17
02 Mar 26SellUS$254,590Joakim WijkstromIndividual30,800US$8.27
02 Mar 26SellUS$350,821Kevin MoranIndividual42,442US$8.27
02 Mar 26SellUS$350,755Timothy WilliamsIndividual42,434US$8.27
02 Mar 26SellUS$350,730Gunther BirznieksIndividual42,431US$8.27
23 Feb 26SellUS$240,900Tage HonoreIndividual30,000US$8.03
07 Aug 25BuyUS$41,500Mihael PolymeropoulosIndividual10,000US$4.15
13 Jun 25SellUS$32,130Stephen MitchellIndividual7,000US$4.59
21 May 25BuyUS$43,995Mihael PolymeropoulosIndividual10,000US$4.40
16 May 25BuyUS$84,472Mihael PolymeropoulosIndividual20,000US$4.22

Insider Trading Volume

Insider Buying: VNDA insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of VNDA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,441,0704.13%
Hedge Funds3,380,9615.72%
General Public13,620,94623%
Institutions39,665,05367.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 62.7% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.2%
BlackRock, Inc.
7,773,535US$56.5m-12.8%no data
6.31%
The Vanguard Group, Inc.
3,731,851US$27.1m4.03%no data
5.72%
Renaissance Technologies LLC
3,380,961US$24.6m-2.76%0.04%
4.08%
Acadian Asset Management LLC
2,410,414US$17.5m8.15%0.02%
3.58%
Dimensional Fund Advisors LP
2,118,428US$15.4m-17.4%no data
3.38%
Aigh Capital Management, LLC
1,998,431US$14.5m0%2.55%
2.84%
Millennium Management LLC
1,679,013US$12.2m-48.4%0.01%
2.69%
Mihael Polymeropoulos
1,588,246US$11.5m-32%no data
2.35%
Geode Capital Management, LLC
1,391,790US$10.1m-0.02%no data
2.14%
State Street Global Advisors, Inc.
1,263,539US$9.2m-0.59%no data
2%
Krensavage Asset Management, LLC
1,180,388US$8.6m0%3.14%
1.87%
Empire Financial Management Company, LLC
1,108,245US$8.1m46.2%1.71%
1.78%
Two Sigma Advisers, LP
1,049,300US$7.6m15.4%0.01%
1.66%
Two Sigma Investments, LP
978,990US$7.1m47.8%0.01%
1.26%
Connor, Clark & Lunn Investment Management Ltd.
743,546US$5.4m-17.8%0.01%
1.2%
Jacobs Levy Equity Management Inc
708,428US$5.2m552%0.02%
1.04%
AQR Capital Management, LLC
616,847US$4.5m-6%no data
0.94%
Federated Hermes, Inc.
554,427US$4.0m-18.7%0.01%
0.85%
Charles Schwab Investment Management, Inc.
500,515US$3.6m0%no data
0.8%
Leap Investments LP
473,800US$3.4m243%0.06%
0.73%
Northern Trust Global Investments
429,113US$3.1m-5.6%no data
0.66%
Morgan Stanley
392,208US$2.9m20.3%no data
0.61%
PSM Vermogensverwaltung GmbH
360,000US$2.6m0%15.11%
0.58%
Susquehanna International Group, LLP
341,049US$2.5m41.3%no data
0.49%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
290,037US$2.1m71%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/19 22:16
End of Day Share Price 2026/04/17 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vanda Pharmaceuticals Inc. is covered by 17 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullArgus Research Company
Olivia BrayerBofA Global Research
Madison Wynne El-SaadiB. Riley Securities, Inc.